TEZSPIRE
TEZSPIRE is an add-on maintenance treatment for people aged 12 and older with severe asthma. TEZSPIRE is not a rescue medication.
Administration and Dosage:
• Administer by subcutaneous injection.
• Recommended dosage is 210 mg administered once every 4 weeks.
Indication:
TEZSPIRE is a thymic stromal lymphopoietin (TSLP) blocker, human monoclonal antibody (IgG2λ), indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.
Common Side Effects:
The most common side effects of TEZSPIRE include: Sore throat, joint and back pain. These are not all the possible side effects.
More information:
Please see full Prescribing Information including Patient Information.
HAVE QUESTIONS?
We are happy to help!
